MedElevator
Войти в исследования Tumori · 2011
Hemolytic uremic syndrome induced by infusion of oxaliplatin: a case report.
Клинический случайСтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Racca Patrizia, Spadi Rosella, Fora Gianluca, Fanchini Laura, Ritorto Giuliana, Ferrari Laura, Pinta Francesco, Lista Patrizia, Ciuffreda Libero
Аннотация
INTRODUCTION: Oxaliplatin is a third-generation platinum compound with proven antitumor activity in the treatment of colorectal cancer. The occurrence of life-threating hemolitic uremic syndrome has been observed after oxaliplatin therapy. The kind of tumor and treatment modalities seem to influence the onset of hemolitic uremic syndrome.
METHODS: The clinical course of the case is reviewed and compared with reports of other similar cases in the literature.
RESULTS: We describe the development of hemolitic uremic syndrome as a result of prolonged oxaliplatin treatment of a colon cancer patient.
CONCLUSIONS: Although this rare event requires the concurrence of other unknown factors, it should be considered in a decision-making setting.
METHODS: The clinical course of the case is reviewed and compared with reports of other similar cases in the literature.
RESULTS: We describe the development of hemolitic uremic syndrome as a result of prolonged oxaliplatin treatment of a colon cancer patient.
CONCLUSIONS: Although this rare event requires the concurrence of other unknown factors, it should be considered in a decision-making setting.